CopyMark Law Group
4.9/5
Drawing for STANDARDEYES

USPTO serial 98335791

STANDARDEYES

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
PETITIONS OFFICE

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with STANDARDEYES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ludomir A. Budzyn

Ludomir A. Budzyn Budzyn IP Law, LLCSuite 328120 Eagle Rock AvenueEast Hanover, NJ 07936

Goods and services

ClassDescriptionStatusFirst use
010eye surgery kits comprising products selected from medical drapes, cannulas, surgical knives, surgical blades, surgical devices and instruments, surgical apparatuses, electrocautery devices, ocular implants made of artificial material, punctal plugs, punctal implants, fluid control bags, surgical sponges, surgical wicks, diagnostic lights, instrument wipes, eye shields, bandages, medical gloves; surgical apparatus and instruments for use in ophthalmic surgery; surgical apparatus and instruments; surgical devices and instruments; medical drapes; surgical sponges; medical glovesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 11, 2026EX3GSOU EXTENSION 3 GRANTED—
Aug 11, 2026EXT3SOU EXTENSION 3 FILED—
Aug 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 3, 2026EX2GSOU EXTENSION 2 GRANTED—
Feb 3, 2026EXT2SOU EXTENSION 2 FILED—
Feb 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 10, 2025CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Dec 10, 2025PC.DPETITION TO DIRECTOR DISMISSED—
Dec 2, 2025APETASSIGNED TO PETITION STAFF—
Aug 18, 2025TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Aug 6, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 5, 2025EX1GSOU EXTENSION 1 GRANTED—
Aug 5, 2025EXT1SOU EXTENSION 1 FILED—
Aug 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 17, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 25, 2024EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 22, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 1, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 1, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2024DOCKASSIGNED TO EXAMINER—
Apr 14, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 29, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance